Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Drug delivery

November 17, 2022 Drug delivery / E-ducation

Magnetic bacteria for drug delivery

Biohybrid bacteria–based microrobots are increasingly recognized as promising externally controllable vehicles for targeted cancer therapy. A range of bacteria, shown

Continue reading

November 16, 2022 CD derivatives / Drug delivery / Pharma applications

First Patient Enrolled in Phase 1 Study of Midatech’s Panobinostat / HPBCD (MTX-110) for Recurrent Glioblastoma

Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announced on 14 November

Continue reading

November 15, 2022 Drug delivery / Pharma applications

Oral Xe-Cyclodextrin for cardiovascular protection

Cardiac hypertrophy often causes impairment of cardiac function. Xenon (Xe), a naturally occurring noble gas, is known to provide neurological

Continue reading

November 14, 2022 Drug delivery / Pharma applications

Per-thiolated cyclodextrins: Nanosized drug carriers providing a prolonged gastrointestinal residence time

Oral delivery is one of the most advantageous routes for drug administration, but due to the short gastrointestinal (GI) residence

Continue reading

November 9, 2022 Drug delivery / Pharma applications

Special Issue “Orally Disintegrating Dosage Forms Based on Cyclodextrins”

Tis Special Issue is for the journal Pharmaceutics (ISSN 1999-4923; Impact Factor: 6.525). Orally disintegrating delivery systems (ODDSs) are pharmaceutical

Continue reading

November 8, 2022 Drug delivery / Pharma applications

Nystatin:β-cyclodextrin inclusion complexes – revisited

The Nystatin/CD complexes appeared in the literature in 1990 with so far 210 publications mentioning both nystatin and cyclodextrin (SCOPUS).

Continue reading

November 7, 2022 CD derivatives / Drug delivery / Pharma applications

Cyclodextrin and folate functionalized polymer nanocarriers: Chain length dependent properties

A  series of β-cyclodextrin and folate-tethered poly(ethylene glycol) with various spacer chain lengths, prepared and characterized using spectroscopic methods. The

Continue reading

November 4, 2022 Drug delivery / Pharma applications

Special Issue “Carbohydrate-Based Carriers for Drug Delivery”

Chitosan, cyclodextrin, alginate, gellan, xanthan gum, cellulose, dextran, pullulan, etc., are some of the most well-known carbohydrate carriers in drug

Continue reading

November 3, 2022 Drug delivery / Pharma applications

Molecular docking assisted exploration on solubilization of poorly soluble drug remdesivir in sulfobutyl ether-beta-cyclodextrin: stabilization of supersaturated solution by changing pH from 1.7 to 3.5

In terms of solubilization effect, it was found that phase solubility of RDV increased significantly from intrinsic 1.7 mmol/L at

Continue reading

November 1, 2022 Drug delivery / Pharma applications

Solid Xenon Carrier Based on α-Cyclodextrin

The inert gas xenon (Xe) is increasingly used in medicine as a universal anesthetic, a regulator of cellular metabolism, and

Continue reading

Posts navigation

«Previous Posts 1 2 3 4 5 … 42 Next Posts»

Recent Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • Small anticancer drug release by light
  • Patent application on reduction of envelope viral particle number in a composition containing cyclodextrin
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (199)
  • CD derivatives (251)
  • Cosmetics and toilettry (21)
  • Drug delivery (416)
  • E-ducation (54)
  • Environmental (76)
  • Events (157)
  • Food (120)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (13)
  • Non-pharma applications (209)
  • Other industrial use (58)
  • Pharma applications (677)
  • Supramolecular systems (25)
  • Uncategorized (41)

Top Posts

  • Bacteroides uniformis and its preferred substrate, α-cyclodextrin, enhance endurance exercise performance in mice and human males
  • Lanosterol eye drops for cataract treatment
  • Waterproof and durable luminescent textiles with HPBCD for marine rescue
  • New book: Cyclodextrins - new Perspectives
  • Small anticancer drug release by light
  • γ-Cyclodextrin/Epigallocatechin-3-gallate Inclusion Complexes as Efficient Antioxidants for Preservation of Shrimp Surimi Products
  • Cyclodextrin Metal-Organic Framework as a Broad-Spectrum Potential Delivery Vehicle for the Gasotransmitters
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease
  • Pilocarpine eye drops (Vuity)
  • Published compilation of the list of approved cyclodextrin-containing drug products

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 521 other subscribers
 

Loading Comments...